SPY400.09-1.63 -0.41%
DIA322.78+0.55 0.17%
IXIC11,662.79-142.21 -1.20%

--SVB Leerink Adjusts Price Target on Alnylam Pharmaceuticals to $96 From $103, Keeps Market Perform Rating

MT Newswires · 04/29/2022 02:08

Please log in to view news